Search Results

A content review of state tobacco pre-emption laws in the US.

• Authors : Azagba, S. (AUTHOR); Ebling, T. (AUTHOR); Jensen, J.K. (AUTHOR)

Subjects: STATE governments -- Law & legislation; SMOKING prevention; SMOKING lawsUNITED States

• Source: Public Health (Elsevier). Sep2023, Vol. 222, p140-146. 7p.

Record details

Characterization of the microstructure of the compositionally complex alloy Al1Mo0.5Nb1Ta0.5Ti1Zr1.

• Authors : Jensen, J.K.¹; Welk, B.A.¹; Williams, R.E.A.²

Subjects: *MICROSTRUCTURE; *ELECTRON microscopy; *ENERGY dispersive X-ray spectroscopy

• Source: Scripta Materialia. Aug2016, Vol. 121, p1-4. 4p.

Record details

610 ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE (ALCAM) AND PROGNOSIS IN ACUTE ISCHEMIC STROKE

• Authors : Smedbakken, L.M.; Jensen, J.K.; Hallén, J.

• Source: Atherosclerosis (Supplements). Jun2011, Vol. 12 Issue 1, p128-129. 2p.

Record details

Compositional variation effects on the microstructure and properties of a refractory high-entropy superalloy AlMo0.5NbTa0.5TiZr.

• Authors : Senkov, O.N.¹ ; Jensen, J.K.²; Pilchak, A.L.¹

Subjects: *MICROSTRUCTURE; *HEAT resistant alloys; *MECHANICAL behavior of materials

• Source: Materials & Design. Feb2018, Vol. 139, p498-511. 14p.

Record details

Soluble CXCL16 and long-term outcome in acute ischemic stroke

• Authors : Ueland, T.^1,2 ; Smedbakken, L.M.¹; Hallén, J.³

Subjects: *ACUTE coronary syndrome; *ISCHEMIA; *HEALTH outcome assessment

• Source: Atherosclerosis (00219150). Jan2012, Vol. 220 Issue 1, p244-249. 6p.

Record details

614 FATTY ACID BINDING PROTEIN 4 AS A BIOMARKER OF CAROTID ATHEROSCLEROSIS AND OUTCOME IN PATIENTS WITH ACUTE ISCHEMIC STROKE

• Authors : Holm, S.; Ueland, T.; Dahl, T.B.

• Source: Atherosclerosis (Supplements). Jun2011, Vol. 12 Issue 1, p129-129. 1p.

Record details

40 DEGARELIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: EFFECT IN METASTATIC PATIENTS AS ASSESSED BY SERUM ALKALINE PHOSPHATASE

• Authors : Schröder, F.H.; Boccon-Gibod, L.; Tombal, B.

• Source: European Urology Supplements. Mar2009, Vol. 8 Issue 4, p130-130. 1p.

Record details

39 COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT

• Authors : Damber, J.E.; Tammela, T.; Abrahamsson, P.A.

• Source: European Urology Supplements. Mar2009, Vol. 8 Issue 4, p130-130. 1p.

Record details

38 DEGARELIX VS. LEUPROLIDE TREATMENT IN PATIENTS WITH ADVANCED PROSTATE CANCER: PSA FAILURES DURING A RANDOMISED, PHASE III TRIAL (CS21)

• Authors : Tombal, B.; Miller, K.; Boccon-Gibod, L.

• Source: European Urology Supplements. Mar2009, Vol. 8 Issue 4, p130-130. 1p.

Record details

537 DEGARELIX COMPARED TO LEUPROLIDE DEPOT 7.5 MG IN A 12- MONTH RANDOMISED, OPEN-LABEL, PARALLEL-GROUP PHASE III STUDY IN PROSTATE CANCER PATIENTS

• Authors : Boccon-Gibod, L.; Klotz, L.; Schröder, H.

• Source: European Urology Supplements. Mar2008, Vol. 7 Issue 3, p205-205. 1p.

Record details